Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors

AIM: Sacubitril-valsartan has proven beneficial in heart failure with reduced ejection fraction. Guidelines recommend initiating half-dose sacubitril-valsartan before up-titration even to patients already on target dose angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers...

Descripción completa

Detalles Bibliográficos
Autores principales: Norberg, Helena, Bergdahl, Ellinor, Lindmark, Krister
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739794/
https://www.ncbi.nlm.nih.gov/pubmed/31772613
http://dx.doi.org/10.1155/2019/6745074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739794/
https://www.ncbi.nlm.nih.gov/pubmed/31772613
http://dx.doi.org/10.1155/2019/6745074

Ejemplares similares